Xin Lang Cai Jing·2026-03-29 23:41Core Viewpoint - Lazard Asset Management LLC has increased its stake in China National Pharmaceutical Group (国药控股) by acquiring 2.096025 million shares at a price of HKD 19.5897 per share, totaling approximately HKD 41.0605 million, resulting in a new holding of about 176 million shares, representing 13.13% of the company [1]. Summary by Category - Investment Activity - Lazard Asset Management LLC purchased 2.096025 million shares of China National Pharmaceutical Group at HKD 19.5897 per share [1]. - The total investment amounted to approximately HKD 41.0605 million [1]. - Shareholding Details - After the acquisition, Lazard's total shareholding in the company reached approximately 176 million shares [1]. - The new shareholding percentage stands at 13.13% [1].